Skip to main content

Helpdesk

Research study about Medido services

An extensive research study on the Medido service has been completed, resulting in a publication.

We are pleased to be able to contribute to research studies that focus on the well-being of the patient.
Naturally, we remain committed to supporting healthcare providers and patients with our services. Cooperation in healthcare leads to solutions for small and large challenges.

Complex medication regimens in Parkinson's disease (PD) result in lower adherence, contributing to suboptimal therapy and clinical deterioration. Medication reminder systems can improve adherence and subsequently improve the symptoms of PD.
This randomised controlled trial assessed the effect of the electronic medication dispenser Medido on physical disability in PD, as an indicator of changes in medication adherence.

Here is a link to the article: LINK.

Credits:
Hannink, K., Brake, L., Oonk, N. et al. 
A randomized controlled efficacy study of the Medido medication dispenser in Parkinson’s disease. 
BMC Geriatr 19, 273 (2019) doi:10.1186/s12877-019-1292-y


Blog overview

Press photo Peter Nijhuis
26 August 2024

Evondos Group appoints Peter Nijhuis as new Managing Director of Evondos Netherlands/Medido

10 June 2024

Navigating Healthcare Redesign: A Journey Towards Autonomy and Well-being

26 August 2021

Benefits of Medido: experiences of a care provider

02 March 2021

Research study about Medido services

Medido and Evondos logo
21 December 2023

Medido and Evondos continue joint mission

19 February 2021

New rules offer more room for digital care - NZa


Sign up for the newsletter
Want to stay informed about the latest developments regarding Medido? Subscribe to our newsletter and receive the latest news about medication assistance in the home.

Follow us on LinkedIn
Will you become part of our business network?
Follow us on Instagram
Receive news messages about Medido?

Webdevelopment © Totoweb | Webdesign © Swirl Design